These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 22955007

  • 21. Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study.
    Üçok A, Çıkrıkçılı U, Ergül C, Tabak Ö, Salaj A, Karabulut S, Correll CU.
    CNS Drugs; 2016 Oct; 30(10):997-1006. PubMed ID: 27356920
    [Abstract] [Full Text] [Related]

  • 22. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [Abstract] [Full Text] [Related]

  • 23. Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program.
    Tang Y, Horvitz-Lennon M, Gellad WF, Lave JR, Chang CH, Normand SL, Donohue JM.
    Psychiatr Serv; 2017 Jun 01; 68(6):579-586. PubMed ID: 28196460
    [Abstract] [Full Text] [Related]

  • 24. Clozapine use in early psychosis.
    Thien K, Bowtell M, Eaton S, Bardell-Williams M, Downey L, Ratheesh A, McGorry P, O'Donoghue B.
    Schizophr Res; 2018 Sep 01; 199():374-379. PubMed ID: 29525463
    [Abstract] [Full Text] [Related]

  • 25. Patterns of antipsychotic prescriptions in patients with schizophrenia in China: A national survey.
    Wang J, Jiang F, Zhang Y, Cotes RO, Yang Y, Liu Z, Ning X, Liu T, Liu Y, Tang YL, Liu H.
    Asian J Psychiatr; 2021 Aug 01; 62():102742. PubMed ID: 34243064
    [Abstract] [Full Text] [Related]

  • 26. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.
    Health Technol Assess; 2006 May 01; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
    Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A.
    JAMA Psychiatry; 2019 May 01; 76(5):499-507. PubMed ID: 30785608
    [Abstract] [Full Text] [Related]

  • 30. [Antipsychotic polypharmacy in high-utilising patients with schizophrenia].
    Schmidt-Kraepelin C, Puschner B, Loos S, Janssen B.
    Psychiatr Prax; 2013 Oct 01; 40(7):380-4. PubMed ID: 23681790
    [Abstract] [Full Text] [Related]

  • 31. Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations.
    Lähteenvuo M, Tiihonen J.
    Drugs; 2021 Jul 01; 81(11):1273-1284. PubMed ID: 34196945
    [Abstract] [Full Text] [Related]

  • 32. Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales.
    Patel MX, Bishara D, Jayakumar S, Zalewska K, Shiers D, Crawford MJ, Cooper SJ.
    Eur Neuropsychopharmacol; 2014 Apr 01; 24(4):499-509. PubMed ID: 24491953
    [Abstract] [Full Text] [Related]

  • 33. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
    Mouaffak F, Tranulis C, Gourevitch R, Poirier MF, Douki S, Olié JP, Lôo H, Gourion D.
    Clin Neuropharmacol; 2006 Apr 01; 29(1):28-33. PubMed ID: 16518132
    [Abstract] [Full Text] [Related]

  • 34. The impact of switching to clozapine on psychiatric hospital admissions: a mirror-image study.
    Kirwan P, O'Connor L, Sharma K, McDonald C.
    Ir J Psychol Med; 2019 Dec 01; 36(4):259-263. PubMed ID: 31747990
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clozapine prescribing in a Canadian outpatient population.
    Alessi-Severini S, Le Dorze JA, Nguyen D, Honcharik P, Eleff M.
    PLoS One; 2013 Dec 01; 8(12):e83539. PubMed ID: 24358290
    [Abstract] [Full Text] [Related]

  • 37. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia.
    Üçok A, Çikrikçili U, Karabulut S, Salaj A, Öztürk M, Tabak Ö, Durak R.
    Int Clin Psychopharmacol; 2015 Sep 01; 30(5):290-5. PubMed ID: 26163875
    [Abstract] [Full Text] [Related]

  • 38. Emerging guidelines for the use of antipsychotic polypharmacy.
    Stahl SM.
    Rev Psiquiatr Salud Ment; 2013 Sep 01; 6(3):97-100. PubMed ID: 23485567
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.